NR8. INTRODUCTION A rare multisystem non Langerhans cell histiocytosis First described by Jakob...

21
NEUROLOGICAL MANIFESTATIONS OF THE ERDHEIM CHESTER DISEASE: MRI FEATURES S BOUABIDI, S JERBI OMEZZINE, Z KHADIMALLAH K MRAIDHA, B ZANTOUR* , HA HAMZA DEPARTEMENT OF MEDICAL IMAGING TAHAR SFAR UNIVERSITY HOSPITAL CENTER, MAHDIA,TUNISIA *DEPARTEMENT OF INTERNAL MEDICINE TAHAR SFAR UNIVERSITY HOSPITAL CENTER,MAHDIA,TUNISIA NR8

Transcript of NR8. INTRODUCTION A rare multisystem non Langerhans cell histiocytosis First described by Jakob...

Page 1: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

NEUROLOGICAL MANIFESTATIONS OF THE ERDHEIM CHESTER DISEASE:

MRI FEATURES

S BOUABIDI, S JERBI OMEZZINE, Z KHADIMALLAH K MRAIDHA, B ZANTOUR* , HA HAMZA

DEPARTEMENT OF MEDICAL IMAGING TAHAR SFAR UNIVERSITY HOSPITAL CENTER, MAHDIA,TUNISIA

*DEPARTEMENT OF INTERNAL MEDICINE TAHAR SFAR UNIVERSITY HOSPITAL CENTER,MAHDIA,TUNISIA

NR8

Page 2: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

INTRODUCTION

A rare multisystem non Langerhans cell histiocytosis

First described by Jakob Erdheim and William Chester in 1930

Since then less than 100 cases have been reported

Defined by the xanthomatous or xanthogranulomatous infiltration of tissues with foamy histiocytes, surrounded by fibrosis.

Page 3: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Clear increase in its incidence due a better understanding of its radiological semiology.

The aetiology remains unknown

The disease can affect multiple organs systems, including musculoskeletal, central nervous, cardiac, pulmonary and renal systems

The most common neurologic manifestation is central diabetes insipidus.

Page 4: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

We report the case of adult-onset ECD with neurologic involvement

To study the MRI appearance of neurological lesions

Page 5: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Materials and methods :

A 50 year old woman Consulted for a polyuria-polydipsia syndrome Physical examination was normal except the presence of a xanthelasma lesions on the eyelidsA water restriction and a DHA test concluded to a central diabetes insipidus X -Rays , Brain MRI centered on the hypothalamic-pituitary axis were performed

Page 6: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Femur X –rays: Symmetric metaphyseal osteosclerosis

MRI brain showed:

Diffuse infiltration of the pituitary stalk massively enhanced after gadolinium injection

Disappearance of the normal T1 hyperintensity of the post hypophysis

Page 7: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Pituitary MRI, coronal T1:Homogeneous diffuse thickening of the pituitary stalk Normal cavernous sinus ( )

Page 8: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Pituitary MRI, coronal T1 GADO:Diffuse intense enhancement of the pituitary stalk( )

Page 9: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Pituitary MRI, sagittal T1GADO:Diffuse thickening of the pituitary stalk massively enhanced with gadolinium

Homogeneous enhancement of the posterior hypophysis

Page 10: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Characterestic radiological findings

+Histological features (a skin biopsy ) with a proliferation of foamy histiocytes that stain for CD68 but not CD1a

Confirmed the diagnosis

Page 11: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Discussion

ECD is a rare disease

A non-Langerhans' cell histiocytosis Defined by infiltration of foamy lipid-laden histiocytes that stain positively for CD68

With characteristic radiological and

histological features

Page 12: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Discussion

Extraskeletal manifestations including involvement of:

Hypothalamus-pituitary axis: diabetes insipidus Lung :diffuse pulmonary fibrosis Heart Retroperitoneum Skin Orbit Liver, Kidneys, Spleen

Page 13: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Discussion

Characterized by a bilateral symmetric sclerosis of the diametaphyseal regions of long bones

Radiographic studies reveal: Bilateral, patchy or diffuse increase in density Sclerosis, and cortical thickening Mainly in the metaphyses Minor changes or sparing of the epiphyses

Page 14: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Discussion

Neurologic Manifestations:

The most common neurologic manifestation is a central diabetes insipidus

The hypothalamic location was found in 40% of intracranial locations

Next in frequency is cerebellar symptoms, usually ataxia of gait.

Page 15: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

MRI of the brain in patients with neurologic symptoms demonstrates:

Intra-axial lesions with T2 hyperintensity

Often intense gadolinium enhancement

The MRI findings mimic a demyelinating process and are often confused with multiple sclerosis

Page 16: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

The MRI findings in patients with diabetes insipidus vary:

Often no structural changes are seen

Loss of the normal T1 hyperintensity of the posterior pituitary

Pituitary enhancement

Enlargement of the infundibulum

Page 17: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Orbital Manifestations

Infiltration of the retroconal fat Optic nerve sheath Retrobulbar, intraconal masses

Retroperitoneal Manifestations

Fat stranding Soft tissue masses Hydronephrosis leading to renal failure and hypertension Periaortic fibrosis

Page 18: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Pulmonary Manifestations:

The most common symptom is progressive dyspnea

Chest X-Rays :diffuse interstitial prominence and pleural thickening

CT typically shows: interlobular septal pleural thickening patchy centrilobular ground glass opacities

Page 19: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Prognosis and Therapy:

Related to the extent of visceral involvement

Most patients die within two to three years after diagnosis congestive heart failure, lung fibrosis or renal insufficiency

Treatment options: corticosteroids, radiotherapy, combination therapy

None have been highly effective

The disease is typically relentless in its course

Page 20: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

Conclusion:

Erdheim Chester disease is a rare non-Langerhans Histiocytosis Characterized by a bilateral symmetric sclerosis of the diametaphyseal regions of long bones

With various extraskeletal manifestationsThe hypothalamic location was found in 40% of intracranial locationsThe typical features on imaging are often the basis of diagnosis, and should be well knownThe disease is typically relentless in its course.

Page 21: NR8. INTRODUCTION  A rare multisystem non Langerhans cell histiocytosis  First described by Jakob Erdheim and William Chester in 1930  Since then less.

References:-Veysler belot c cacoub p;caparros lefebvre d ;erdheim chester disease,clinical and radiologic characteristics of59cases ; medecine 1996;-Gary g ;poehling;daniel m ;erdheim chester diseases ;a case report ;clin ortho relat research ;1982-Gomez ch ;diard f ;chatell gf;moinard m ;imagerie de la maladie d’erdheim chester , j radiol 1996-Ramesh p babu ;thomas a ;lansen ;army chaburn ;erdheim chester disease of the central nervous system ;report of two cases ;j neurosurg 1997-Bohlega s ; alwatban j; tulbah a ;bakheet sm;cerebral manifestation of erdheim disease ;clinical and radiologic findings am acad of neurology 1997Chollet p;eyremandi r;lesieur l;arne jl; la maladie d’erdheim chester ; une etiologie rare de tumeur retrobulbaire jfr ophtalmo ;1994-Valmaggla c; neuweller j; fretz c; gottlob i; a case of erdheim chester disease with orbital involvement ;arch ophtalmo;1997-Rosenberg i; wechsler j; koenig f, maladie d’erdheim chester forme multiviscerale revelee par une exophtalmie ;rev med interne 1986-Veyssler belot ;wechsler j; cacoub p; erdheim chester disease ;survey of a rare non langerhans histiocytosis ;jfr ophtalmo 1997-Offert h ;hannouche d ; frau e ;doyon d quillard j ;schaison g ; orbital erdheim chester disease ; jfr ophtalmo ;1995;